GB1561244A - Broparestrol based therapeutic compositions - Google Patents

Broparestrol based therapeutic compositions Download PDF

Info

Publication number
GB1561244A
GB1561244A GB11585/77A GB1158577A GB1561244A GB 1561244 A GB1561244 A GB 1561244A GB 11585/77 A GB11585/77 A GB 11585/77A GB 1158577 A GB1158577 A GB 1158577A GB 1561244 A GB1561244 A GB 1561244A
Authority
GB
United Kingdom
Prior art keywords
broparestrol
trans
isomer
composition
cis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB11585/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laroche Navarron SA
Original Assignee
Laroche Navarron SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laroche Navarron SA filed Critical Laroche Navarron SA
Priority to GB11585/77A priority Critical patent/GB1561244A/en
Priority to IL54220A priority patent/IL54220A/xx
Priority to FR7806693A priority patent/FR2383665A1/fr
Priority to CH255878A priority patent/CH627076A5/fr
Priority to IE497/78A priority patent/IE46481B1/en
Priority to DE19782811166 priority patent/DE2811166A1/de
Priority to ZA00781539A priority patent/ZA781539B/xx
Priority to BE185983A priority patent/BE864957A/xx
Priority to PH20889A priority patent/PH14956A/en
Priority to CA299,224A priority patent/CA1111768A/en
Priority to JP3002778A priority patent/JPS53121939A/ja
Priority to NL7802938A priority patent/NL7802938A/xx
Priority to NZ186722A priority patent/NZ186722A/xx
Priority to AU34275/78A priority patent/AU515727B2/en
Publication of GB1561244A publication Critical patent/GB1561244A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/035—Halogenated hydrocarbons having aliphatic unsaturation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB11585/77A 1977-03-18 1977-03-18 Broparestrol based therapeutic compositions Expired GB1561244A (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GB11585/77A GB1561244A (en) 1977-03-18 1977-03-18 Broparestrol based therapeutic compositions
IL54220A IL54220A (en) 1977-03-18 1978-03-07 Pharmaceutical compositions comprising trans-broparestrol
FR7806693A FR2383665A1 (fr) 1977-03-18 1978-03-08 Nouvelle composition therapeutique a base de trans broparestrol
CH255878A CH627076A5 (en) 1977-03-18 1978-03-09 Therapeutic composition based on the trans-broparestrol
IE497/78A IE46481B1 (en) 1977-03-18 1978-03-10 Improvements in or relating to broparestrol based therapeutic compositions
DE19782811166 DE2811166A1 (de) 1977-03-18 1978-03-15 Arzneimittel, enthaltend trans-broparestrol
ZA00781539A ZA781539B (en) 1977-03-18 1978-03-15 New trans-broparestrol based therapeutic composition
BE185983A BE864957A (fr) 1977-03-18 1978-03-16 Nouvelles composition therapeutique a base de trans broparestrol
PH20889A PH14956A (en) 1977-03-18 1978-03-16 Trans-broparestrol based therapeutic
CA299,224A CA1111768A (en) 1977-03-18 1978-03-17 Trans-broparestrol based therapeutic composition
JP3002778A JPS53121939A (en) 1977-03-18 1978-03-17 Novel treating composition
NL7802938A NL7802938A (nl) 1977-03-18 1978-03-17 Nieuw therapeutisch preparaat met trans- -broparestrol als actieve stof.
NZ186722A NZ186722A (en) 1977-03-18 1978-03-17 Therapeutic compositions containing transbroparestrol
AU34275/78A AU515727B2 (en) 1977-03-18 1978-03-17 Trans broparestrol composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB11585/77A GB1561244A (en) 1977-03-18 1977-03-18 Broparestrol based therapeutic compositions

Publications (1)

Publication Number Publication Date
GB1561244A true GB1561244A (en) 1980-02-13

Family

ID=9988941

Family Applications (1)

Application Number Title Priority Date Filing Date
GB11585/77A Expired GB1561244A (en) 1977-03-18 1977-03-18 Broparestrol based therapeutic compositions

Country Status (14)

Country Link
JP (1) JPS53121939A (de)
AU (1) AU515727B2 (de)
BE (1) BE864957A (de)
CA (1) CA1111768A (de)
CH (1) CH627076A5 (de)
DE (1) DE2811166A1 (de)
FR (1) FR2383665A1 (de)
GB (1) GB1561244A (de)
IE (1) IE46481B1 (de)
IL (1) IL54220A (de)
NL (1) NL7802938A (de)
NZ (1) NZ186722A (de)
PH (1) PH14956A (de)
ZA (1) ZA781539B (de)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870219A (en) * 1986-05-23 1989-09-26 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
US4990703A (en) * 1987-03-17 1991-02-05 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
US5030764A (en) * 1986-05-23 1991-07-09 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
US5030765A (en) * 1986-05-23 1991-07-09 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US7459445B2 (en) 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055622A (en) * 1986-05-23 1991-10-08 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
US4870219A (en) * 1986-05-23 1989-09-26 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
US5001276A (en) * 1986-05-23 1991-03-19 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
US5030764A (en) * 1986-05-23 1991-07-09 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
US5030765A (en) * 1986-05-23 1991-07-09 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
US4935560A (en) * 1986-05-23 1990-06-19 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene & indane derivatives
US4990703A (en) * 1987-03-17 1991-02-05 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
US6844334B2 (en) 2000-03-10 2005-01-18 Endeavor Pharmaceuticals (3) and (6) substitued estrogenic compounds
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US7179799B2 (en) 2000-03-10 2007-02-20 Barr Laboratories, Inc. (3) and (6) substituted estrogenic compounds
US7459445B2 (en) 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US7749989B2 (en) 2000-03-10 2010-07-06 Duramed Pharmaceuticals, Inc. Estrogenic compounds, methods of using and methods of administering the same
US8227454B2 (en) 2000-03-10 2012-07-24 Duramed Pharmaceuticals, Inc. Estrogenic compounds, pharmaceutical compositions and formulations comprising the same
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same

Also Published As

Publication number Publication date
IE46481B1 (en) 1983-06-29
ZA781539B (en) 1979-03-28
JPS53121939A (en) 1978-10-24
IL54220A (en) 1981-12-31
PH14956A (en) 1982-02-05
AU515727B2 (en) 1981-04-30
IE780497L (en) 1978-09-18
NL7802938A (nl) 1978-09-20
IL54220A0 (en) 1978-06-15
FR2383665A1 (fr) 1978-10-13
CH627076A5 (en) 1981-12-31
NZ186722A (en) 1981-10-19
DE2811166A1 (de) 1978-09-28
CA1111768A (en) 1981-11-03
BE864957A (fr) 1978-09-18
AU3427578A (en) 1979-09-20
FR2383665B1 (de) 1980-10-24

Similar Documents

Publication Publication Date Title
KR100612161B1 (ko) 전립선암 치료를 위한 티로신 키나아제 억제제 및 화학적거세법의 조합
US6319911B1 (en) Prevention of ovarian cancer by administration of progestin products
Roy et al. Effects of clomiphene on the physiology of reproduction in the rat
RU2139056C1 (ru) Гормональная заместительная терапия
RU2114621C1 (ru) Композиции и способ предупреждения зачатия
RU2245713C2 (ru) Прерывистая гормонозаместительная терапия низкими дозами эстрогена
EP0844884A2 (de) Endothelin-antagonisten und endothelin-synthase-inhibitoren zur prävention und behandlung von beschwerden im zusammenhang mit der uteruskontraktilität präeklampsie atherosklerotischen gefä erkrankungen hypertonie und zur hormonsubstitutionstherapie
DE4429398C2 (de) Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Kontrazeption
RU2157203C2 (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования эндометриоза
GB1561244A (en) Broparestrol based therapeutic compositions
Zondek Hypophyseal tumors induced by estrogenic hormone
US20030125229A1 (en) Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
Schöler et al. Biological properties of 9, 10-isomeric steroids
Scublinsky et al. THE CONTRACEPTIVE ACTION OF IMPEDING OESTROGENS
CA2136140C (en) Carcinostatic for hormonotherapy containing dienogest as effective component
Mellish et al. Experiments on the biological properties of stilbestrol and stilbestryl dipropionate
Wakeling The potential for a novel pure anti-oestrogen
EP0850647B1 (de) Verwendung von 11-substituierten Steroiden zur Herstellung von Medikamenten mit unterschiedlicher östrogenischen Wirkung
KR20010032056A (ko) 황체 호르몬-항 황체 호르몬 투약법
KR100729311B1 (ko) 호르몬 대체 요법(ｈｒｔ)용 조성물의 성분으로서의메조프로게스틴 (프로게스테론 수용체 조절물질)
Velardo Influence of purified adrenal hormones and adrenocorticotropin on progesterone in decidual tissue formation
Lindsay et al. The effect of 5-hydroxytryptamine and of an amine oxidase inhibitor on experimental deciduomata in mice
JPH0474332B2 (de)
RU2067001C1 (ru) Способ снижения риска заболевания раком молочной железы
WILSON JR The levels of prostaglandins in the uterus of nonpregnant, pregnant and progesterone-treated ewes

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee